China Resources Double Crane Pharmaceutical Co., Ltd. (600062)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
16. 40
+0.04
+0.2445%
¥
19.25B Market Cap
14.62 P/E Ratio
0.4% Div Yield
11.16M Volume
0 Eps
¥ 16.36
Previous Close Want to track 600062 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600062 trading today higher at ¥16.4, an increase of 0.2445% from yesterday's close, completing a monthly increase of 2.2444% or ¥0.36. Over the past 12 months, 600062 stock lost -10.3825%.
600062 pays dividends to its shareholders, with the most recent payment made on Jul 28, 2026. The next estimated payment will be in In 5 months on Jan 28, 2027 for a total of ¥0.379.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
China Resources Double Crane Pharmaceutical Co., Ltd. has completed 6 stock splits, with the recent split occurring on Aug 16, 2018.
The company's stock is traded on one exchange.
600062 Chart
People also search for
China Resources Double Crane Pharmaceutical Co., Ltd. (600062) FAQ
What is the stock price today?
The current price is ¥16.40.
On which exchange is it traded?
China Resources Double Crane Pharmaceutical Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600062.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.4%.
What is its market cap?
As of today, the market cap is 19.25B.
Has China Resources Double Crane Pharmaceutical Co., Ltd. ever had a stock split?
China Resources Double Crane Pharmaceutical Co., Ltd. had 6 splits and the recent split was on Aug 16, 2018.
China Resources Double Crane Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Wenchao Lu CEO | SSE Exchange | CNE000000Q94 ISIN |
| CN Country | 12,269 Employees | 28 Jul 2026 Last Dividend | 16 Aug 2018 Last Split | 6 May 1997 IPO Date |
Overview
China Resources Double-Crane Pharmaceutical Co.,Ltd., established in 1939 and headquartered in Beijing, is a prominent player in the pharmaceutical industry within the People's Republic of China. As a subsidiary under Beijing Pharmaceutical Group Co., Ltd., the company has carved out a significant presence, focusing on the development, production, and sale of a varied range of pharmaceutical products. Its dedication to healthcare and medicine is reflected in its broad offering of pharmaceutical solutions designed to meet diverse medical needs.
Products and Services
The company's extensive portfolio spans various therapeutic areas, showcasing their commitment to addressing a wide array of health concerns:
- Blood Pressure: A range of pharmaceutical products aimed at managing and treating hypertension, ensuring patients have access to effective medications for controlling high blood pressure.
- Blood Sugar: Dedicated solutions for the effective control and management of diabetes, offering patients a means to manage their blood sugar levels through medication.
- Injection: A variety of injectable medications for different medical uses, including emergency care, chronic conditions, and treatments requiring direct delivery into the bloodstream.
- Lipid-lowering: Medications designed to help reduce cholesterol levels, contributing to the prevention of cardiovascular diseases and promoting heart health.
- Pediatrics: Specialized pharmaceutical products targeted at addressing the health needs of infants, children, and adolescents, ensuring age-appropriate treatments across a range of pediatric conditions.
- Nephrology: A spectrum of products focused on kidney health and the treatment of renal diseases, supporting patients in managing their kidney-related conditions effectively.
- API: Active Pharmaceutical Ingredients (API), which are crucial in the production of various medications, ensuring high-quality components for pharmaceutical manufacturing.
- Pharmaceutical: A broad category that includes a wide range of medications and health care products beyond the specific areas mentioned, catering to the overall well-being and specific medical needs of patients.
- Other: A miscellaneous category that encompasses products and services not explicitly listed, indicating the company's versatility and commitment to addressing emerging health concerns.
Contact Information
Address: No. 1, Lize East 2nd Road, Beijing, China, 100102
Phone: 86 10 6474 2227
Website: https://www.dcpc.com
